# IT Tech Packaging, Inc.: overview ITP · NYSE · CIK 1358190 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/itp.md) · [Financials](/companies/itp/financials.md) · [Filings](/companies/itp/filings.md) · [Insiders](/companies/itp/insiders.md) Latest reported revenue: [$25.6m](/filings/0001213900-25-110001.md) for Q3 FY2025, three months to 2025-09-30, from the 10-Q filed Nov 13, 2025 (XBRL us-gaap:Revenues, accession 0001213900-25-110001). ## Last eight quarters | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [21.0 d](/filings/0001213900-25-031072.md) | [6.9](/filings/0001213900-25-041500.md) | [26.2](/filings/0001213900-25-076676.md) | [25.1](/filings/0001213900-25-110001.md) | [17.6 d](/filings/0001213900-25-031072.md) | [10.9](/filings/0001213900-25-041500.md) | [24.8](/filings/0001213900-25-076676.md) | [25.6](/filings/0001213900-25-110001.md) | | Gross margin | % | [1.2% d](/filings/0001213900-25-031072.md) | [5.8%](/filings/0001213900-25-041500.md) | [12.4%](/filings/0001213900-25-076676.md) | [7.6%](/filings/0001213900-25-110001.md) | [6.3% d](/filings/0001213900-25-031072.md) | [0.8%](/filings/0001213900-25-041500.md) | [5.1%](/filings/0001213900-25-076676.md) | [7.9%](/filings/0001213900-25-110001.md) | | Operating margin | % | [(18.1%) d](/filings/0001213900-25-031072.md) | [(51.0%)](/filings/0001213900-25-041500.md) | [2.1%](/filings/0001213900-25-076676.md) | [(5.8%)](/filings/0001213900-25-110001.md) | [(21.5%) d](/filings/0001213900-25-031072.md) | [(31.0%)](/filings/0001213900-25-041500.md) | [(7.1%)](/filings/0001213900-25-076676.md) | [(3.9%)](/filings/0001213900-25-110001.md) | | Net margin | % | [(19.0%) d](/filings/0001213900-25-031072.md) | [(54.6%)](/filings/0001213900-25-041500.md) | [(0.3%)](/filings/0001213900-25-076676.md) | [(7.9%)](/filings/0001213900-25-110001.md) | [(22.9%) d](/filings/0001213900-25-031072.md) | [(32.2%)](/filings/0001213900-25-041500.md) | [(7.9%)](/filings/0001213900-25-076676.md) | [(5.7%)](/filings/0001213900-25-110001.md) | | Diluted EPS | $ per share | not reported | [(0.37)](/filings/0001213900-25-041500.md) | [(0.01)](/filings/0001213900-25-076676.md) | [(0.20)](/filings/0001213900-25-110001.md) | not reported | [(0.35)](/filings/0001213900-25-041500.md) | [(0.16)](/filings/0001213900-25-076676.md) | [(0.11)](/filings/0001213900-25-110001.md) | | Free cash flow | $m | [(7.7) d](/filings/0001213900-25-031072.md) | [0.6](/filings/0001213900-25-041500.md) | [0.7 d](/filings/0001213900-25-076676.md) | [1.2 d](/filings/0001213900-25-110001.md) | [3.5 d](/filings/0001213900-25-031072.md) | [(2.5)](/filings/0001213900-25-041500.md) | [1.3 d](/filings/0001213900-25-076676.md) | [1.5 d](/filings/0001213900-25-110001.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [101](/filings/0001213900-22-012344.md) | [161](/filings/0001213900-23-022564.md) | [100](/filings/0001213900-24-026607.md) | [86.5](/filings/0001213900-25-031072.md) | [75.8](/filings/0001213900-25-031072.md) | | Gross margin | % | [5.6%](/filings/0001213900-22-012344.md) | [6.8%](/filings/0001213900-23-022564.md) | [4.7%](/filings/0001213900-24-026607.md) | [1.2%](/filings/0001213900-25-031072.md) | [8.8%](/filings/0001213900-25-031072.md) | | Operating margin | % | [(5.4%)](/filings/0001213900-22-012344.md) | [0.9%](/filings/0001213900-23-022564.md) | [(5.3%)](/filings/0001213900-24-026607.md) | [(11.1%)](/filings/0001213900-25-031072.md) | [(10.8%)](/filings/0001213900-25-031072.md) | | Net margin | % | [(5.5%)](/filings/0001213900-22-012344.md) | [0.6%](/filings/0001213900-23-022564.md) | [(16.5%)](/filings/0001213900-24-026607.md) | [(11.5%)](/filings/0001213900-25-031072.md) | [(13.0%)](/filings/0001213900-25-031072.md) | | Diluted EPS | $ per share | [(0.21)](/filings/0001213900-21-022128.md) | [0.10](/filings/0001213900-23-022564.md) | [(1.66)](/filings/0001213900-24-026607.md) | [(0.99)](/filings/0001213900-25-031072.md) | [(0.98)](/filings/0001213900-25-031072.md) | | Free cash flow | $m | [(5.0)](/filings/0001213900-22-012344.md) | [(27.5)](/filings/0001213900-23-022564.md) | [6.2](/filings/0001213900-24-026607.md) | [(9.4)](/filings/0001213900-25-031072.md) | [6.0](/filings/0001213900-25-031072.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/itp/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $46.3k | 250,000 | | Reduced −58,100 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $31.5k | 165,800 | Call | Added +22,200 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $24.9k | 134,388 | | Added +115,305 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $17.4k | 93,785 | | Added +4,371 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $11.2k | 60,512 | | Added +10,471 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $8.3k | 45,042 | | New +45,042 | | [TWO SIGMA SECURITIES, LLC](/funds/1450144.md) | 2026-06-30 | $8.1k | 43,526 | | Added +28,310 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $6.2k | 33,600 | Call | Reduced −52,900 | | [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $3.8k | 19,739 | | New +19,739 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $196 | 1,059 | | Added +786 | ## Recent filings [All 413 filings](/companies/itp/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-09 | 13:30 ET | [8-K](/filings/0001213900-26-108255.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-108255 | | 2026-10-06 | 15:00 ET | [8-K](/filings/0001213900-26-107056.md) | 4.01 Change of auditor | 0001213900-26-107056 | | 2026-09-18 | 21:00 ET | [8-K](/filings/0001213900-26-101474.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-101474 | | 2026-09-01 | 16:50 ET | [8-K](/filings/0001213900-26-096111.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-096111 | | 2026-04-22 | 20:15 ET | [8-K](/filings/0001213900-26-046612.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-046612 | | 2026-04-20 | 20:30 ET | [8-K](/filings/0001213900-26-045628.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-045628 | | 2025-11-13 | 21:17 ET | [10-Q](/filings/0001213900-25-110001.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110001 | | 2025-10-31 | 16:02 ET | [8-K](/filings/0001213900-25-104520.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-104520 | | 2025-09-11 | 20:15 ET | [8-K](/filings/0001213900-25-086833.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-086833 | | 2025-09-08 | 20:15 ET | [DEF 14A](/filings/0001213900-25-085528.md) | Proxy statement, period 2025-10-31 | 0001213900-25-085528 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2024](/filings/0001213900-25-031072.md), filed Apr 11, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1358190 - Tickers: ITP - Exchange: NYSE - SIC code: 2670 Converted Paper & Paperboard Prods (No Contaners/Boxes) - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.